Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 101 - 110 of 200 for wx. (0.09 seconds)

Charles River Laboratories defended its $1.6 billion...
The 8th ChinaBio® Investor Forum, held in Shanghai,...
An investment firm, Jana Partners LLC, announced its...
Qiming Venture Partners announced a 250 million RMB...
Charles River Labs defended its $1.6 billion acquisition...
Sino Biopharmaceutical raised $79 million for a single,...
Charles River Labs’ spectacular announcement that...
Trauson (Jiangsu) Holdings, an orthopedic products...
Charles River Laboratories and WuXi PharmaTech said they...
WuXi PharmaTech (药明康德) reported upbeat Q2...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here